Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development•
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Humana Press

9781588299307, 9781597452748

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_3 ◽

2008 ◽

pp. 57-91 ◽

Cited By ~ 10

Author(s):

Ryan P. Bender ◽

Neil Osheroff

Keyword(s):

Dna Topoisomerases ◽

Chemotherapeutic Treatment

Download Full-text

Plks as Novel Targets for Cancer Drug Design

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_12 ◽

2008 ◽

pp. 271-290

Author(s):

Wei Dai ◽

Yali Yang ◽

Ning Jiang

Keyword(s):

Drug Design ◽

Cancer Drug ◽

Novel Targets

Download Full-text

RB-Pathway

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_1 ◽

2008 ◽

pp. 1-17

Author(s):

Erik S. Knudsen ◽

Wesley A. Braden

Keyword(s):

Rb Pathway

Download Full-text

CDK Inhibitors as Anticancer Agents

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_6 ◽

2008 ◽

pp. 135-162

Author(s):

Timothy A. Yap ◽

L. Rhoda Molife ◽

Johann S. de Bono

Keyword(s):

Anticancer Agents ◽

Cdk Inhibitors

Download Full-text

Antiproliferation Inhibitors Targeting Aurora Kinases

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_11 ◽

2008 ◽

pp. 243-269

Author(s):

Kishore Shakalya ◽

Daruka Mahadevan

Keyword(s):

Aurora Kinases

Download Full-text

Targeting the p53/MDM2 Pathway for Cancer Therapy

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_2 ◽

2008 ◽

pp. 19-56

Author(s):

Christian Klein ◽

Lyubomir T. Vassilev

Keyword(s):

Cancer Therapy

Download Full-text

CHFR as a Potential Anticancer Target

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_7 ◽

2008 ◽

pp. 163-176

Author(s):

Minoru Toyota ◽

Lisa Kashima ◽

Takashi Tokino

Keyword(s):

Anticancer Target

Download Full-text

Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_13 ◽

2008 ◽

pp. 291-309

Author(s):

Brian Gabrielli ◽

Frankie Stevens ◽

Heather Beamish

Keyword(s):

Cell Cycle ◽

Histone Deacetylase ◽

Target Cell ◽

Histone Deacetylase Inhibitors ◽

Cell Cycle Checkpoints ◽

Heterochromatin Structure

Download Full-text

Kinesin Motor Inhibitors as Effective Anticancer Drugs

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_9 ◽

2008 ◽

pp. 207-226

Author(s):

Vasiliki Sarli ◽

Athanassios Giannis

Keyword(s):

Anticancer Drugs ◽

Kinesin Motor

Download Full-text

Antimicrotubule Agents

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development• ◽

10.1007/978-1-59745-274-8_8 ◽

2008 ◽

pp. 177-205 ◽

Cited By ~ 1

Author(s):

Miguel A. Villalona-Calero ◽

Larry Schaaf ◽

Robert Turowski

Keyword(s):

Antimicrotubule Agents

Download Full-text

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development•Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Humana Press

DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer

Plks as Novel Targets for Cancer Drug Design

RB-Pathway

CDK Inhibitors as Anticancer Agents

Antiproliferation Inhibitors Targeting Aurora Kinases

Targeting the p53/MDM2 Pathway for Cancer Therapy

CHFR as a Potential Anticancer Target

Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?

Kinesin Motor Inhibitors as Effective Anticancer Drugs

Antimicrotubule Agents

Checkpoint Responses in Cancer Therapy - Cancer Drug Discovery and Development•
Latest Publications